All ResearchPublished

Anxiety and Depression

Published:
Total participants:
3 adult female participants
Person from behind wearing gray hoodie, holding ScienceDirect book with orange cover

Recurrent depression and anxiety can be resistant to monotherapies, including psychotherapy, eye movement desensitization and reprocessing (EMDR), and selective serotonin reuptake inhibitors (SSRIs). Over a 12-week tPBM protocol, participants reported improvements in sleep quality, irritability, and depression scores, though anxiety outcomes varied across measures. These preliminary findings suggest that tPBM may offer supportive benefits alongside conventional treatments.

Read the publication

Partners

  • Neuronic Corporation
  • King's College London

Enable chat

Our live chat is powered by HubSpot and requires marketing cookies. Enable marketing cookies to start a conversation with our team.